MedPath

兆科(广州)眼科药物有限公司

Ownership
-
Established
2016-06-16
Employees
-
Market Cap
-
Website
www.zkoph.com.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

7

NMPA:7

Drug Approvals

Latanoprost and Timolol Maleate Eye Drops

Product Name
拉坦噻吗滴眼液
Approval Number
国药准字H20253633
Approval Date
Mar 18, 2025
NMPA

Travoprost Eye Drops

Product Name
曲伏前列素滴眼液
Approval Number
国药准字H20249647
Approval Date
Dec 1, 2024
NMPA

Travoprost and Timolol Maleate Eye Drops

Product Name
曲伏噻吗滴眼液
Approval Number
国药准字H20249645
Approval Date
Dec 1, 2024
NMPA

Latanoprost Eye Drops

Product Name
拉坦前列素滴眼液
Approval Number
国药准字H20249433
Approval Date
Nov 22, 2024
NMPA

Bimatoprost Eye Drops

Product Name
贝美前列素滴眼液
Approval Number
国药准字H20244892
Approval Date
Oct 15, 2024
NMPA

Bimatoprost and Timolol Maleate Eye Drops

Product Name
贝美素噻吗洛尔滴眼液
Approval Number
国药准字H20233190
Approval Date
Feb 14, 2023
NMPA

Deproteinized Calf Blood Extract Eye Gel

Product Name
小牛血去蛋白提取物眼用凝胶
Approval Number
国药准字H20080261
Approval Date
Nov 4, 2022
NMPA

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath